Acumen Pharmaceuticals, Inc. (ABOS)
3.18
+0.09
(+2.91%)
USD |
NASDAQ |
Sep 04, 16:00
3.17
-0.01
(-0.31%)
After-Hours: 20:00
Acumen Pharmaceuticals Total Liabilities (Quarterly) : 58.74M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.74M |
| March 31, 2026 | 46.15M |
| December 31, 2025 | 52.57M |
| September 30, 2025 | 49.05M |
| June 30, 2025 | 54.82M |
| March 31, 2025 | 48.96M |
| December 31, 2024 | 57.18M |
| September 30, 2024 | 49.77M |
| June 30, 2024 | 44.97M |
| March 31, 2024 | 38.93M |
| December 31, 2023 | 43.15M |
| September 30, 2023 | 6.098M |
| Date | Value |
|---|---|
| June 30, 2023 | 8.531M |
| March 31, 2023 | 8.779M |
| December 31, 2022 | 7.812M |
| September 30, 2022 | 6.613M |
| June 30, 2022 | 5.159M |
| March 31, 2022 | 3.998M |
| December 31, 2021 | 5.147M |
| September 30, 2021 | 1.489M |
| June 30, 2021 | 4.518M |
| March 31, 2021 | 31.18M |
| December 31, 2020 | 6.367M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 13.24B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 116.01M |
| Shareholders Equity (Quarterly) | 57.26M |
| Debt to Equity Ratio | 0.5526 |
| Current Ratio | 2.466 |
| Net Debt Paydown Yield | -0.19% |